ChengDa Pharmaceuticals Co. Ltd. Cash Flow Quality Index
ChengDa Pharmaceuticals Co. Ltd. cash flow quality index. ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Quality Index of 2.11x as of December 2023. Operating cash flow of CN¥192.07 Million exceeds net income of CN¥90.98 Million, indicating high earnings quality where cash backs reported profits. Explore ChengDa Pharmaceuticals Co. Ltd. (301201) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ChengDa Pharmaceuticals Co. Ltd. (2019–2023)
Cash flow quality index of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2023. Historical Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See how leveraged is ChengDa Pharmaceuticals Co. Ltd.'s balance sheet to measure how much of total assets are equity-financed.
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Quality Index by Year (2019–2023)
ChengDa Pharmaceuticals Co. Ltd. cash flow quality index by year from 2019 to 2023. Year-by-year earnings quality comparison for ChengDa Pharmaceuticals Co. Ltd.. For the full cash flow conversion analysis, see ChengDa Pharmaceuticals Co. Ltd. cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.11x | CN¥192.07 Million | CN¥90.98 Million | ▲ +371.6% |
| 2022 | 0.45x | CN¥47.67 Million | CN¥106.48 Million | ▼ -45.9% |
| 2021 | 0.83x | CN¥83.14 Million | CN¥100.44 Million | ▼ -22.2% |
| 2020 | 1.06x | CN¥128.97 Million | CN¥121.17 Million | ▼ -14.5% |
| 2019 | 1.25x | CN¥67.52 Million | CN¥54.22 Million | — |